AAAlireza Amouheidari

Alireza Amouheidari

*This is an algorithmically generated author record based on publicly available information.

Alireza Amouheidari has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Dosiomics-based detection of dose distribution variations in helical tomotherapy for prostate cancer patients: influence of treatment plan parameters

    by Marziyeh Mirzaeiyan, Ali Akhavan, Simin Hemati, Mahnaz Etehadtavakol, Alireza Amouheidari, Atoosa Adibi, Hossein Khanahmad, Zahra Sharifonnasabi, Parvaneh Shokrani

    The stability of dosiomics features (DFs) and dose-volume histogram (DVH) parameters for detecting disparities in helical tomotherapy planned dose distributions was assessed. Treatment plans of 18 prostate patients were recalculated using the followings: field width (WF) (2.5 vs. 5), pitch factor (PF) (0.433 vs. 0.444), and modulation factor (MF) (2.5 vs. 3). From each of the eight plans per patient, ninety-three original and 744 wavelet-based DFs were extracted, using 3D-Slicer software, across six regions including: target volume (PTV), pelvic lymph nodes (PTV-LN), PTV + PTV-LN (PTV-All), one cm rind around PTV-All (PTV-Ring), rectum, and bladder. For the resulting DFs and DVH parameters, the coefficient of variation (CV) was calculated, and using hierarchical clustering, the features were classified into low/high variability. The significance of parameters on instability was analyzed by a three-way analysis of variance. All DF’s were stable in PTV, PTV-LN, and PTV-Ring (average CV (\(\overline{CV })\) ≤ 0.36). Only one feature in the bladder (\(\overline{CV }\) = 0.9), rectum (\(\overline{CV }\) = 0.4), and PTV-All (\(\overline{CV }\) = 0.37) were considered unstable due to change in MF in the bladder and WF in the PTV-All. The value of \(\overline{CV }\) for the wavelet features was much higher than that for the original features. Out of 225 unstable wavelet features, 84 features had \(\overline{CV }\) ≥ 1. The CVs for all the DVHs remained very small (\(\overline{CV }\)< 0.06). This study highlights that the sensitivity of DFs to changes in tomotherapy planning parameters is influenced by the region and the DFs, particularly wavelet features, surpassing the effectiveness of DVHs.


  • Prediction of Normal Tissue Complication Probability (NTCP) After Radiation Therapy Using Imaging and Molecular Biomarkers and Multivariate Modelling

    by Zahra Alirezaei, Alireza Amouheidari, Sajjad Iraji, Masoud Hassanpour, Seyed Hosein Hejazi, Fariba Davanian, Mohammad Torabi Nami, Sedighe Rastaghi, Parvaneh Shokrani, Christina I. Tsien, et al.

    The aim of this study was to design a predictive radiobiological model of normal brain tissue in low-grade glioma following radiotherapy based on imaging and molecular biomarkers. Fifteen patients with primary brain tumors prospectively participated in this study and underwent radiation therapy. Magnetic resonance imaging (MRI) was obtained from the patients, including T1- and T2-weighted imaging and diffusion tensor imaging (DTI), and a generalized equivalent dose (gEUD) was calculated. The radiobiological model of the normal tissue complication probability (NTCP) was performed using the variables gEUD; axial diffusivity (AD) and radial diffusivity (RD) of the corpus callosum; and serum protein S100B by univariate and multivariate logistic regression XLIIIrd Sir Peter Freyer Memorial Lecture and Surgical Symposium (2018). Changes in AD, RD, and S100B from baseline up to the 6 months after treatment had an increasing trend and were significant in some time points (P-value < 0.05). The model resulting from RD changes in the 6 months after treatment was significantly more predictable of necrosis than other univariate models. The bivariate model combining RD changes in Gy40 dose-volume and gEUD, as well as the trivariate model obtained using gEUD, RD, and S100B, had a higher predictive value among multivariate models at the sixth month of the treatment. Changes in RD diffusion indices and in serum protein S100B value were used in the early-delayed stage as reliable biomarkers for predicting late-delayed damage (necrosis) caused by radiation in the corpus callosum. Current findings could pave the way for intervention therapies to delay the severity of damage to white matter structures, minimize cognitive impairment, and improve the quality of life of patients with low-grade glioma.


  • Investigating the number of radiation fields in intensity-modulated radiotherapy plans of optic nerve sheath meningioma patients using dose gradient index

    by Fahimeh Mazloomi, Iraj Abedi, Ahmad Shanei, Fatemeh Dalvand, Alireza Amouheidari

    Purpose : In optic nerve radiotherapy, vital organs are very close to the target volume, they are highly sensitive to radiation and have low dose tolerance. In this regard, evaluating dose fall-off steepness around the target volume is required to assess various intensity-modulated radiation therapy (IMRT) plans in the treatment of the optic nerve sheath meningioma (ONSM) patients. Materials and Methods : Thirteen ONSM patients were analyzed with three IMRT techniques, including three (IMRT-3F), five (IMRT-5F), and seven fields (IMRT-7F). These plans were studied using D mean , D max , D 2% , D 98% , V 100% , uniformity index (UI), homogeneity index (HI), conformity index (CI), and specifically the dose gradient indices (DGIs). Results : The values of D max and D mean for IMRT-3F, IMRT-5F and IMRT-7F were (5637.42 ± 57.08, 5322.84 ± 83.86), (5670.51 ± 67.87, 5383.00 ± 58.45), and (5692.99 ± 31.65, 5405.72 ± 51.73), respectively, which were increased with increment in the number of IMRT fields from 3 to 7. The UI and HI indices were significantly different between IMRT-3F and IMRT-7F (p = 0.010 and p = 0.005, respectively), and CI was close to the ideal value (0.99 ± 0.01) in IMRT-7F. The significant findings of the dose gradient indices represented smaller values in IMRT-7F, which led to a faster dose fall-off, particularly at the 70%-85% isodose levels around the target. Conclusion : Increasing the number of radiation fields in IMRT treatment plans of ONSM patients had a considerable difference in both the dosimetric parameters of the target volume and at-risk organs, as well as the dose gradient indices. Overall, IMRT-7F could be considered as a preferred technique in the treatment of this meningioma.


  • Open Access

    PrACTiC: A Predictive Algorithm for Chemoradiotherapy-Induced Cytopenia in Glioblastoma Patients

    by Alireza Amouheidari, Zahra Alirezaei, Stefan Rauh, Masoud Hassanpour

    Background. Chemotherapy-induced cytopenia is the most frequent side effect of chemoradiotherapy in glioblastoma patients which may lead to reduced delivery of treatment. This study aims to develop a predictive model that is able to forecast the cytopenia induced by temozolomide (TMZ) during concomitant chemoradiotherapy. Methods. Medical records of 128 patients with newly diagnosed glioblastoma were evaluated to extract the baseline complete blood test before and during the six weeks of chemoradiotherapy to create a dataset for the development of ML models. Using the constructed dataset, different ML algorithms were trained and tested. Results. Our proposed algorithm achieved accuracies of 85.6, 88.7, and 89.3 in predicting thrombocytopenia, lymphopenia, and neutropenia, respectively. Conclusions. The algorithm designed and developed in this study, called PrACTiC, showed promising results in the accurate prediction of thrombocytopenia, neutropenia, and lymphopenia induced by TMZ in glioblastoma patients. PrACTiC can provide valuable insight for physicians and help them to make the necessary treatment modifications and prevent the toxicities.


  • Open Access

    Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients

    by Amirhosein Kefayat, Alireza Amouheidari, Fatemeh Ghahremani, Zahra Alirezaei

    Background: Investigation of novel blood‐circulating agents as potential biomarkers for glioblastoma multiforme (GBM) patients’ diagnosis and monitoring has gained lots of attention, due to limitations of imaging modalities and invasive tissue biopsy procedures. The present study aims to assess the diagnostic and prognostic values of preoperative stem cell factor (SCF) plasma level in GBM patients.Methods: Preoperative plasma samples from 58 GBM patients and 20 patients with nonglial tumors and 30 healthy controls were obtained. SCF levels were measured by employing the enzyme‐linked immunosorbent assay test and the values were compared between these three groups. Then, the association of SCF plasma level and tumor volume, progression‐free survival (PFS), and overall survival (OS) for the GBM patients were evaluated.Results: Mean preoperative SCF plasma level of the GBM patients (2.80 ± 1.52 ng/ml) was significantly higher (p < 0.0001) than the healthy controls (0.80 ± 0.24 ng/ml) and patients with nonglial tumor (1.41 ± 0.76 ng/ml). Receiver operating characteristic analysis revealed that the preoperative SCF plasma level could distinguish the GBM patients from healthy controls and patients with nonglial tumors with the area under curve values of 0.915 and 0.790, respectively. However, no significant association was observed between the GBM patients’ preoperative SCF plasma levels and tumors’ volume (Spearman Rho correlation coefficient, 0.1847; 95% CI, p = 0.1652). The GBM patients were divided into two subgroups based on mean preoperative SCF plasma levels (2.80 ng/ml). No significant difference was observed between the patients’ PFS (p = 0.3792) and OS (p = 0.1469) at these two subgroups.Conclusion: Taking together, the SCF plasma level can serve as a novel diagnostic blood‐circulating biomarker for patients with GBM. However, its plasma level is not correlated with GBM patients’ tumor volume, PFS, or OS.


  • Open Access

    Early Detection of Radiation‐Induced Injury and Prediction of Cognitive Deficit by MRS Metabolites in Radiotherapy of Low‐Grade Glioma

    by Zahra Alirezaei, Alireza Amouheidari, Masoud Hassanpour, Fariba Davanian, Sajjad Iraji, Parvaneh Shokrani, Mohammad-Reza Nazem-Zadeh

    Purpose. To compare the sensitivity of MRS metabolites and MoCA and ACE‐R cognitive tests in the detection of radiation‐induced injury in low grade glioma (LGG) patients in early and early delayed postradiation stages. Methods. MRS metabolite ratios of NAA/Cr and Cho/Cr, ACE‐R and MoCA cognitive tests, and dosimetric parameters in corpus callosum were analyzed during RT and up to 6‐month post‐RT for ten LGG patients. Results. Compared to pre RT baseline, a significant decline in both NAA/Cr and Cho/Cr in the corpus callosum was seen at the 4th week of RT, 1, 3, and 6‐month post‐RT. These declines were detected at least 3 months before the detection of declines in cognitive functions by ACE‐R and MoCA tools. Moreover, NAA/Cr alterations at 4th week of RT and 1‐month post‐RT were significantly negatively correlated with the mean dose received by the corpus callosum, as well as the corpus callosum 40 Gy dose volume, i.e., the volume of the corpus callosum receiving a dose greater than 40 Gy. Conclusion. MRS‐based biomarkers may be more sensitive than the state‐of‐the‐art cognitive tests in the prediction of postradiation cognitive impairments. They would be utilized in treatment planning and dose sparing protocols, with a specific focus on the corpus callosum in the radiation therapy of LGG patients.